MedTrace Logo

Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation

NCT00677664 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-05-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of Copaxone injections in retinal function and integrity in diabetic patients who underwent pan-retinal photocoagulation.

Conditions

Interventions

DRUG

Glatiramer acetate (Copaxone)

Drug was offered by subcutaneous administration one week prior and in the three sections of PRP, one per week.

DRUG

Mannitol

Drug was offered by subcutaneous administration one week prior and in the three sections of PRP, one per week.

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Augusto Paranhos Jr, MD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2008-07-31
Completion
2008-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00677664 on ClinicalTrials.gov